Atlas Trials

Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea

Clinical trial NCT02184910 · UNKNOWN

Trial details

NCT number
NCT02184910
Sponsor
Yonsei University
Status
UNKNOWN
Study type
OBSERVATIONAL
Atrophic Gastritis
Start date
2013-12-01
Primary completion
2023-12-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.